Mary Bird Perkins Cancer Center - Baton Rouge
4950 Essen Ln
Baton Rouge, Louisiana 70809
(225) 767-0847 https://www.marybird.org

Use our guide to learn which trials are right for you!

Mary Bird Perkins Cancer Center (MBPCC) and Our Lady of the Lake Regional Medical Center (OLOL) have been accredited together since 1992 by The American College of Surgeons, which is the gold-standard for community-based cancer care. However, the National Cancer Institute's competitive selection of the Cancer Center as a National Community Cancer Centers Program (NCCCP) site in 2007 quickly accelerated the partnership's progress.

Together through NCCCP, MBPCC and OLOL and only 20 other facilities throughout the country helped develop a best practice model for community cancer care until the program's completion in summer 2014. NCCCP collaboration has helped the Cancer Center launch or enhance many of its programs, including survivorship services, early phase clinical trials, screenings for disparate populations and multidisciplinary cancer care teams that focus on colorectal, lung, skin and head and neck cancers.

In 2012, MBPCC and OLOL entered into an agreement signifying an even closer, integrated alliance in providing cancer care to the surrounding communities. Jointly branded as Mary Bird Perkins - Our Lady of the Lake Cancer Center, the two organizations is moving forward together in creating an even more unified experience for patients, includes a phased-in integration of the two organization's cancer services, processes and interactions.

Today, Mary Bird Perkins - Our Lady of the Lake Cancer Center is looking to the future with a $23 million renovation and expansion underway that will help create a more personalized and streamlined process for cancer patients and their families. The construction project, slated for completion in early 2015, includes modernizing building systems and expanding areas for additional and enhanced services. For more information, visit our renovation/expansion page.

We've found
3 trials
at this facility
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
HEAD AND NECK CANCER Clinical Trial
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Baton Rouge, LA
Click here to add this to my saved trials